@FiercePharma: Sanofi deal could bring $22M bonus for Termeer. Article | Follow @FiercePharma
> Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm. Teva's release | Article
> Swiss drugmaker Novartis has received approval from EU and Canadian regulators to buy a minority stake in Alcon, making it easier for it to take full control of the U.S. eyecare group. Report
> Dr. Reddy's has launched Cresp, its new biosimilar version of the Amgen anemia drug Aranesp, in India. Dr. Reddy's release | Story
> King Pharmaceuticals' quarterly profit was cut in half as sales of its muscle-relaxant Skelaxin plunged 95 percent due to generic competition, but overall results slightly topped expectations. Item
> In a twist to the tale of drug patent infringement cases in the U.S., Indian drug company Lupin has sued Ranbaxy Laboratories in a U.S. court. News
Biotech News
@FierceBiotech: Mayo Clinic to launch center for social media. Report | Follow @FierceBiotech
@JohnCFierce: It's rare to see a Ph3 drug with the kind of compelling, clean profile that telaprevir has. | Follow @JohnCFierce
> Elan, Transition push ahead with troubled Alzheimer's drug. Item
> TetraLogic nabs $32 million round for lead cancer therapy. Article
> Endo buying partner in pain Penwest for $168 million. News
> Report: China readies $1.5 billion plan to bolster biotech. Report
> Vertex's telaprevir cuts hep C treatment time in half. Story
Biotech Research News
> Gene recipe regenerates damaged heart tissue. Story
> Scientists look to newt to regenerate tissue in mice. Article
> Debate over chimps pits lawmakers against researchers. News
> Investigators create cancer-fighting T cell receptors. Item
> Lab accident opens door to new fertility treatment. Article
> Leptin fades as a prime obesity target. News
Manufacturing News
> Indian packager Bilcare looks west for expansion. Report
> Gilead SEC filing anticipates FDA warning letter. Item
> FDA to skip legal review of warning letters. News
> Distribution change affects supply chain balance of power. Article
> Private labeler Activis revs up for Tylenol shortfall. Item
> Sun enjoys fleeting profit boost from oxaliplatin. Story
And Finally... A new study suggests that a 50-year-old drug commonly used as an anesthetic for humans and animals--and abused, as the drug called Special K--may deliver almost instant relief in some of the most troublesome cases of bipolar depression. Story